| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-06 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.19 | 6e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |